Correction: Oncogenomics of c-Myc transgenic mice reveal novel regulators of extracellular signaling, angiogenesis and invasion with clinical significance for human lung adenocarcinoma

Yari Ciribilli; Jürgen Borlak

doi:10.18632/oncotarget.26489

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Oncogenomics of c-Myc transgenic mice reveal novel regulators of extracellular signaling, angiogenesis and invasion with clinical significance for human lung adenocarcinoma

PDF | How to cite

Oncotarget. 2018; 9:37269-37269. https://doi.org/10.18632/oncotarget.26489

Metrics: PDF 1398 views | ?

Yari Ciribilli^1,2 and Jürgen Borlak²

¹ Centre for Integrative Biology (CIBIO), University of Trento, 38123 Povo (TN), Italy
² Centre for Pharmacology and Toxicology, Hannover Medical School, 30625 Hannover, Germany

Published: December 14, 2018

This article has been corrected: The given microarray GEO information in the Materials and Methods section refers to a previous study from 2008 (PMID: 18498649); it has been listed incorrectly. The proper listing is shown below:

The microarray study is MIAME compliant, and the raw data have been deposited in GEO database (GSE54829; http://www.ncbi.nlm.nih. gov/geo).

Original article: Oncotarget. 2017; 8:101808-101831. DOI: https://doi.org/10.18632/oncotarget.21981.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 26489

Publication Alerts

Post-Publication Promotion

Publication Discount

Corrections:

Correction: Oncogenomics of c-Myc transgenic mice reveal novel regulators of extracellular signaling, angiogenesis and invasion with clinical significance for human lung adenocarcinoma